Mark W. Frohlich

Mark W. Frohlich

DirectoratRigel Pharmaceuticals· In proxies 2024–2025

Mark W. Frohlich is Director of Rigel Pharmaceuticals.

Experience

  1. Rigel PharmaceuticalsPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role +260%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?